Cellistic

Overview

Cellistic is a specialized CDMO dedicated exclusively to iPSC-derived cell therapy and regenerative medicine. The company provides integrated support across the full development and manufacturing lifecycle, from cell line development through GMP manufacturing, process development, analytical development, quality control testing, and product release.

Core Capabilities

Technology Platforms:

• Pulse™ Cell Line Development Platform — powered by proprietary STAR-CRISPR™ gene editing and Allo Chassis™ edited cell lines
• Cellistic Echo™ Platform — designed for scalable GMP manufacturing

Service Scope:

• iPSC cell line development and differentiation process establishment
• Process development and optimization
• Analytical method development and characterization
• GMP manufacturing at scale
• Quality control and release testing
• Technology transfer support

Therapeutic Focus

Cellistic supports a broad range of immune and regenerative cell therapy applications, with particular expertise in:

• Allogeneic cell therapy development (moving beyond autologous or donor-derived approaches)
• iPSC-derived immune cell therapies
• Regenerative medicine programs

Regulatory & Infrastructure

Headquartered in Mont-Saint-Guibert, Belgium, Cellistic operates a purpose-built, single-location facility that is:

• EMA-certified for iPSC cell therapy GMP manufacturing
• FDA-compliant
• PMDA-compliant

The integrated facility houses all development and manufacturing capabilities, enabling close client collaboration and alignment on shared manufacturing and commercialization goals.